AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific resp...
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period
About this item
Full title
Author / Creator
Huang, Yunda , Seaton, Kelly E , Casapia, Martin , Polakowski, Laura , De Rosa, Stephen C , Cohen, Kristen , Yu, Chenchen , Elizaga, Marnie , Paez, Carmen , Miner, Maurine D , Kelley, Colleen F , Maenza, Janine , Keefer, Michael , Lama, Javier R , Sobieszczyk, Magdalena , Buchbinder, Susan , Baden, Lindsey R , Lee, Carter , Gulati, Vineeta , Sinangil, Faruk , Montefiori, David , McElrath, M. Juliana , Tomaras, Georgia D , Robinson, Harriet L , Goepfert, Paul , on behalf of the NIAID-funded HIV Vaccine Trials Network (HVTN) 114 Study Team and NIAID-funded HIV Vaccine Trials Network (HVTN) 114 Study Team
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
AbstractBackgroundEliciting durable humoral immunity with sufficient breadth and magnitude is important for HIV-1 vaccine design. The HVTN 114 vaccine trial evaluated different boost regimens administered after a 7-year rest period in participants previously enrolled in HVTN 205, who received either three MVA/HIV62B (MMM) or two DNA and two MVA/HIV...
Alternative Titles
Full title
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period
Authors, Artists and Contributors
Author / Creator
Seaton, Kelly E
Casapia, Martin
Polakowski, Laura
De Rosa, Stephen C
Cohen, Kristen
Yu, Chenchen
Elizaga, Marnie
Paez, Carmen
Miner, Maurine D
Kelley, Colleen F
Maenza, Janine
Keefer, Michael
Lama, Javier R
Sobieszczyk, Magdalena
Buchbinder, Susan
Baden, Lindsey R
Lee, Carter
Gulati, Vineeta
Sinangil, Faruk
Montefiori, David
McElrath, M. Juliana
Tomaras, Georgia D
Robinson, Harriet L
Goepfert, Paul
on behalf of the NIAID-funded HIV Vaccine Trials Network (HVTN) 114 Study Team
NIAID-funded HIV Vaccine Trials Network (HVTN) 114 Study Team
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8853668
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8853668
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2021.06.066
